Show simple item record

dc.contributor.authorSelby, Nicholas
dc.contributor.authorTaal, Maarten
dc.date.accessioned2022-11-15T14:17:51Z
dc.date.available2022-11-15T14:17:51Z
dc.identifier.citationLancet. 2022 Nov 12;400(10364):1657-1659en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12904/15965
dc.description.abstractConflict of interest statement: NMS reports grants from the UK National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme, NIHR Health Technology Assessment programme (unrelated to the topic of this comment), and Kidney Research UK (validation of an algorithm for real-time prediction of intradialytic hypotension using continuous non-invasive blood pressure monitoring); speaker's fees from GE and Fresenius (unrelated, contrast associated acute kidney injury, sodium removal during dialysis); consultancy fees (paid to institution) from AstraZeneca (unrelated); and is a member of the Trial Steering Committees for the TOP-CKD trial, STOP-ACEi trial, and H4RT trial (unrelated, TOP-CKD trial and STOP-ACEi are in chronic kidney disease, H4RT is a trial of high flux haemodiafiltration). MWT reports grant funding from Fresenius Medical Care (HaemoDialysis interventions to REduce Multi-Organ Dysfunction and Enhance quality of Life) and Kidney Research UK (validation of an algorithm for real-time prediction of intradialytic hypotension using continuous non-invasive blood pressure monitoring); speaker's fees (paid to institution) from Fresenius (Life 2020 conference: Hemodynamic Stress in Hemodialysis); and is a member of the Data Safety Monitoring Committee for the NightLife Study, a randomised trial of nocturnal haemodialysis (NIHR CPMS 45387). NMS and MWT report a patent US provisional application (62/855,069, measuring pressure waves in dialysis lines to derive continuous arterial blood pressure) and have previously collaborated with Professor Christopher W McIntyre, one of the authors of the MyTEMP trial.
dc.subjectHaemodialysisen_US
dc.subjectKidney Injuryen_US
dc.subjectAcute Kidney Injuryen_US
dc.titleEvaluating the results of MyTEMP, a cluster randomised trial of lower temperature haemodialysis: the end of a cool idea?en_US
dc.typeArticleen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionNAen_US
rioxxterms.versionofrecorddoi: 10.1016/S0140-6736en_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.panelUnspecifieden_US
refterms.dateFirstOnline2022-11
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


This item appears in the following Collection(s)

Show simple item record